Publications by authors named "Zaima Mazorra"

Claim this Profile
T
Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors.
Zaima Mazorra, Haslen H Cáceres-Lavernia, Elia Nenínger-Vinageras, Leslie M Varona-Rodríguez, Carmen Elena Viada

Biomedicines· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
Rachel Evans, Kelvin Lee, Paul K Wallace, Mary Reid, Jason Muhitch, Zaima Mazorra

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Gisela María Suárez, Mauricio Catalá, Yadira Peña, Susana Portela, Ana Laura Añé-Kourí, Zaima Mazorra

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer.
Gisela María Suárez, Ana Laura Añé-Kourí, Amnely González, Patricia Lorenzo-Luaces, Elia Neninger, Zaima Mazorra

Cancer Immunol Immunother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.
Lázaro Manuel Filgueira, Julio Betancourt Cervantes, Orlando Adolfo Lovelle, Carlos Herrera, Carlos Figueredo, Zaima Mazorra

Immunotherapy· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.
Yayquier Díaz, Mayra Ramos-Suzarte, Yordanis Martín, Néstor Antonio Calderón, William Santiago, Zaima Mazorra

Gerontology· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
Danay Saavedra, Ana Laura Añé-Kourí, Naivy Sánchez, Lázaro Manuel Filgueira, Julio Betancourt, Zaima Mazorra

Immun Ageing· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Armando Caballero, Lázaro M Filgueira, Julio Betancourt, Naivy Sánchez, Carlos Hidalgo, Zaima Mazorra

Clin Transl Immunology· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule.
Xitlally Popa, Beatriz García, Karla P Fuentes, Vivian Huerta, Karen Alvarez, Zaima Mazorra

Oncoimmunology· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly.
Danay Saavedra, Silvia A Fuertes, Gisela M Suárez, Amnely González, Patricia Lorenzo-Luaces, Zaima Mazorra

Exp Gerontol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nimotuzumab: beyond the EGFR signaling cascade inhibition.
Zaima Mazorra, Lisset Chao, Anabel Lavastida, Belinda Sanchez, Mayra Ramos

Semin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIMAvax-EGF: Toward long-term survival of advanced NSCLC.
Danay Saavedra, Elia Neninger, Camilo Rodriguez, Carmen Viada, Zaima Mazorra

Semin Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy.
Anet Valdes-Zayas, Zuyen Gonzalez, Vladimir Mulens, Aliz M Vega, Kirenia Perez, Zaima Mazorra

J Immunother· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients.
Zaima Mazorra, Anabel Lavastida, Fernando Concha-Benavente, Anet Valdés, Raghvendra M Srivastava

Front Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial.
Iraida Caballero, Lazaro E Aira, Anabel Lavastida, Xitlally Popa, Javier Rivero, Zaima Mazorra

Front Pharmacol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.
Lazaro E Aira, Patricia Hernández, Dinorah Prada, Araceli Chico, Jorge A Gómez, Zaima Mazorra

MAbs· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients.
Pedro C Rodriguez, Xitllaly Popa, Odeth Martínez, Silvia Mendoza, Eduardo Santiesteban, Zaima Mazorra

Clin Cancer Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients.
Danay Saavedra, Beatriz García, Patricia Lorenzo-Luaces, Amnely González, Xitlally Popa, Zaima Mazorra

Cancer Immunol Immunother· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab.
Lazaro E Aira, Alejandro López-Requena, Dasha Fuentes, Liset Sánchez, Teresita Pérez, Zaima Mazorra

MAbs· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, multicenter, placebo-controlled clinical trial of racotumomab-alum vaccine as switch maintenance therapy in advanced non-small cell lung cancer patients.
Sailyn Alfonso, Anet Valdés-Zayas, Eduardo R Santiesteban, Yoanna I Flores, Fernando Areces, Zaima Mazorra

Clin Cancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: Results from a controlled study in metastatic breast cancer patients.
Vladimir Mulens, Ana de la Torre, Patricia Marinello, Ronald Rodríguez, Jorge Cardoso, Zaima Mazorra

Hum Vaccin· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining an EGF-based cancer vaccine with chemotherapy in advanced nonsmall cell lung cancer.
Elia Neninger, Beatriz García Verdecia, Tania Crombet, Carmen Viada, Susana Pereda, Zaima Mazorra

J Immunother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization with a GM3 ganglioside nanoparticulated vaccine confers an effector CD8(+) T cells-mediated protection against melanoma B16 challenge.
Zaima Mazorra, Circe Mesa, Audry Fernández, Luis E Fernández

Cancer Immunol Immunother· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
Beatriz García, Elia Neninger, Ana de la Torre, Idrissa Leonard, Rocío Martínez, Zaima Mazorra

Clin Cancer Res· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.
Mariano R Gabri, Zaima Mazorra, Giselle V Ripoll, Circe Mesa, Luis E Fernandez

Clin Cancer Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis